ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 3370 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 3237
1 LEFLUNOMIDE 3152
2 ADALIMUMAB 3138
3 METHOTREXATE 3134
4 ETANERCEPT 3049
5 TOCILIZUMAB 3024
6 INFLIXIMAB 3022
7 CERTOLIZUMAB PEGOL 2966
8 ABATACEPT 2914
9 SULFASALAZINE 2906
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 131 0.5240
1 PSEUDOEPHEDRINE HYDROCHLORIDE 1887 0.4103
2 PSEUDOEPHEDRINE HCL 1923 0.3545
3 CAFFEINE CITRATE 328 0.3254
4 CORTISONE ACETATE 2032 0.3068
5 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 60 0.2765
6 DESOXIMETASONE 2698 0.2687
7 CHLORHEXIDINE GLUCONANTE 1 0.2000
8 CETIRIZINE HYDROCHLORIDE TABLETS 2068 0.1340
9 SARILUMAB 1354 0.1262
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 3152 0.0377
1 Interleukin-6 Receptor Antagonist [EPC] 3050 0.0347
2 Aminosalicylate [EPC] 2906 0.0305
3 Selective T Cell Costimulation Modulator [EPC] 2914 0.0290
4 Standardized Chemical Allergen [EPC] 332 0.0270
5 Histamine-1 Receptor Antagonist [EPC] 899 0.0263
6 Interleukin-12 Antagonist [EPC] 1513 0.0217
7 Interleukin-23 Antagonist [EPC] 1513 0.0163
8 CD20-directed Cytolytic Antibody [EPC] 2790 0.0148
9 Vitamin D [EPC] 2819 0.0117
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE